Home>Topics>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. RPT-EU clears GSK's acquisition of Novartis vaccines with conditions

    Headlines

    Wed, 28 Jan 2015

    BRUSSELS, Jan 28 (Reuters) - The European Commission said on Wednesday it had approved drugmaker GlaxoSmithKline 's acquisition of Novartis' vaccines business, as well as a consumer healthcare joint venture between the two.

  2. EU clears GSK's acquisition of Novartis vaccines with conditions

    Headlines

    Wed, 28 Jan 2015

    BRUSSELS, Jan 28 (Reuters) - The European Commission said on Wednesday it had approved drugmaker GlaxoSmithKline 's acquisition of Novartis' vaccines business, as well as a consumer healthcare joint venture between the two.

  3. BRIEF- GlaxoSmithkline says Philip Hampton appointed chairman of nominations committee

    Headlines

    Tue, 27 Jan 2015

    * Philip Hampton has been appointed chairman of nominations committee with effect from today

  4. First GSK Ebola vaccine shipment due to arrive in Liberia

    Headlines

    Fri, 23 Jan 2015

    LONDON, Jan 23 (Reuters) - The first batch of GlaxoSmithKline 's experimental Ebola vaccine has been shipped to West Africa and is expected to arrive in Liberia later on Friday, the British drugmaker said.

  5. US health officials say Ebola treatment trial to start soon in Liberia

    Headlines

    Thu, 22 Jan 2015

    3 clinical trials starting in the next two weeks in Liberia to determine if an Ebola treatment being developed by GlaxoSmithKline and another by Newlink Genetics with Merck & Co are safe and effective.

  6. Morningstar's 2014 CEO of the Year

    Headlines

    Wed, 21 Jan 2015

    develop drug resistance, and they only need to make one copayment. Gilead will see new competitive threats in HIV; GlaxoSmithKline recently received FDA approval for a single-tablet regimen called Triumeq and could introduce a single-tablet

  7. MSF slams expensive vaccines, urges GSK and Pfizer to cut prices

    Headlines

    Tue, 20 Jan 2015

    LONDON, Jan 20 (Reuters) - the international charity Medecins Sans Frontieres urged drugmakers GlaxoSmithKline and Pfizer on Tuesday to slash the price of their pneumococcal vaccines to $5 per child in poor countries.

  8. GSK's nicotine patches and gum feel the heat from e-cigarettes

    Headlines

    Fri, 16 Jan 2015

    LONDON, Jan 16 (Reuters) - GlaxoSmithKline is feeling the heat from the rapid growth in electronic cigarettes, with enthusiasm for the nicotine delivery devices dampening sales of the British drugmaker's patches and gum, its chief executive said.

  9. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

    Video Reports

    Fri, 2 Jan 2015

    Coffina: I also want to just talk about [TICKER: GSK ] GlaxoSmithKline ( GSK ). This company, I think, was our top-ranked ..... end of the spectrum, Pfizer and [TICKER: GSK ] GlaxoSmithKline didn't score as well. In both cases, the companies

    GlaxoSmithKline GSK found at 2:52

    line looks very, very challenging. Coffina: I also want to just talk GSK GlaxoSmithKline ( GSK ). This company, I think, was our top-ranked firm last year. It's toward the bottom this year. So obviously, some things didn't go
  10. NewLink, GSK get U.S. funding for faster development of Ebola vaccines

    Headlines

    Tue, 23 Dec 2014

    Dec 23 (Reuters) - The U.S. Department of Health and Human Services (HHS) awarded contracts worth a total of about $43 million to NewLink Genetics Corp and GlaxoSmithKline Plc for faster development of two Ebola vaccines.

« Prev12345Next »
Content Partners